Genmab — December 2012
-
det er det første antistof der viser monoterapi effekt
-
wouw Paul, you just added value
-
Torben Plesner: måske doseeskalering i 8 mg protokollen
-
plesner bruger Rituximab
-
og ofa
-
og dara opfører sig ens
-
Harvard bryder ind igen
-
8 mg er godt fordi det nok er en minimal effekt dosis til at forstå
-
hvad der sker
-
Så er der Nordea Market
-
så er der OFA
-
Hvornår kommer der labelupdate
-
GSK siger 2015 eller 2016
-
Frontline kan ske 2014
-
GSK er lidt mere konservativ
-
ok. vi har noget at drøfte her senere
-
FL nå sit endpoint, men vil de være blowout data
-
men det er givet at det vil betyde mersalg
-
Så jeg vurderer lige her: at labelekspansion tidligst kan nåes midt 2014
-
Peter Wellford
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind